Cargando…
GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney, and its diagnosis and prognosis still lack reliable biomarkers. Glutathione peroxidase 1 (GPX1) has been identified to be highly expressed in a variety of human malignancies. However, few studies have studied the expression...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949109/ https://www.ncbi.nlm.nih.gov/pubmed/31844035 http://dx.doi.org/10.18632/aging.102555 |